Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L T Bacheler

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Journal of Medicinal Chemistry|May 23, 2000
Inhibition of clinically relevant mutant variants of HIV-1 by quinazolinone non-nucleoside reverse transcriptase inhibitorsJ W Corbett, S S Ko, J D Rodgers, et al.
Chemistry & Biology|November 18, 1998
Design and selection of DMP 850 and DMP 851: the next generation of cyclic urea HIV protease inhibitorsJ D Rodgers, P Y Lam, B L Johnson, et al.
Chemistry & Biology|April 1, 1996
Improved cyclic urea inhibitors of the HIV-1 protease: synthesis, potency, resistance profile, human pharmacokinetics and X-ray crystal structure of DMP 450C N Hodge, P E Aldrich, L T Bacheler, et al.
Journal of Medicinal Chemistry|August 30, 1996
Cyclic HIV protease inhibitors: synthesis, conformational analysis, P2/P2' structure-activity relationship, and molecular recognition of cyclic ureasP Y Lam, Y Ru, P K Jadhav, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Journal of Medicinal Chemistry|May 23, 2000
Inhibition of clinically relevant mutant variants of HIV-1 by quinazolinone non-nucleoside reverse transcriptase inhibitorsJ W Corbett, S S Ko, J D Rodgers, et al.
Chemistry & Biology|November 18, 1998
Design and selection of DMP 850 and DMP 851: the next generation of cyclic urea HIV protease inhibitorsJ D Rodgers, P Y Lam, B L Johnson, et al.
Chemistry & Biology|April 1, 1996
Improved cyclic urea inhibitors of the HIV-1 protease: synthesis, potency, resistance profile, human pharmacokinetics and X-ray crystal structure of DMP 450C N Hodge, P E Aldrich, L T Bacheler, et al.
Journal of Medicinal Chemistry|August 30, 1996
Cyclic HIV protease inhibitors: synthesis, conformational analysis, P2/P2' structure-activity relationship, and molecular recognition of cyclic ureasP Y Lam, Y Ru, P K Jadhav, et al.
Pageof 4